Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Effects of adalimumab therapy on disease activity and interferon-?-mediated biochemical pathways in patients with rheumatoid arthritis.

Effects of adalimumab therapy on disease activity and interferon-?-mediated biochemical pathways in patients with rheumatoid arthritis. Autoimmunity. 2011 May; 44(3):235-42.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.